P

Inventor

MEVELLEC LAURENCE ANNE

FR30 patents
⚠️ This page may combine multiple inventors who share the name “MEVELLEC LAURENCE ANNE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JANSSEN PHARMACEUTICA NV

17 patents
US7196094B2Mar 27, 2007

Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives

JANSSEN PHARMACEUTICA NV11 citations84
US7173040B2Feb 6, 2007

Farnesyl transferase inhibiting 6-[(substituted phenyl)methyl]-quinoline and quinazoline derinazoline derivatives

JANSSEN PHARMACEUTICA NV21 citations84
US7803795B2Sep 28, 2010

Phthalazine derivatives as parp inhibitors

JANSSEN PHARMACEUTICA NV7 citations73
US7635706B2Dec 22, 2009

5HT4-antagonistic 4-(aminomethyl)-piperidine benzamides

JANSSEN PHARMACEUTICA NV2 citations62
US7652040B2Jan 26, 2010

Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists

JANSSEN PHARMACEUTICA NV5 citations61
US9598396B2Mar 21, 2017

Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors

JANSSEN PHARMACEUTICA NV0 citations51
US9150540B2Oct 6, 2015

Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors

JANSSEN PHARMACEUTICA NV1 citations51
US10894793B2Jan 19, 2021

Bicyclic pyridine, pyrazine, and pyrimidine derivatives as PI3K beta inhibitors

JANSSEN PHARMACEUTICA NV0 citations48
US12492194B2Dec 9, 2025

HPK1 inhibitors

JANSSEN PHARMACEUTICA NV0 citations47
US12486264B2Dec 2, 2025

Bicyclic HPK1 inhibitors

JANSSEN PHARMACEUTICA NV0 citations47
US7638535B2Dec 29, 2009

4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists

JANSSEN PHARMACEUTICA NV0 citations41
US7732464B2Jun 8, 2010

Heterocyclic substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists

JANSSEN PHARMACEUTICA NV0 citations40
US7498347B2Mar 3, 2009

Hydroxycarbonylphenyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4 antagonists

JANSSEN PHARMACEUTICA NV0 citations40
US10202387B2Feb 12, 2019

Heterocyclyl linked imidazopyridazine derivatives as PI3KB inhibitors

JANSSEN PHARMACEUTICA NV0 citations39
US10087187B2Oct 2, 2018

Imidazopyridazine derivatives as PI3KB inhibitors

JANSSEN PHARMACEUTICA NV0 citations39
US10280170B2May 7, 2019

Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazine derivatives and 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepine derivatives as Ros1 inhibitors

JANSSEN PHARMACEUTICA NV0 citations35
US10342795B2Jul 9, 2019

Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrimidine derivatives and 2,3-dihydro-1H-imidazo[1,2-b]pyrazole derivatives as ROS1 inhibitors

JANSSEN PHARMACEUTICA NV0 citations32

ASTEX THERAPEUTICS LTD

3 patents

ANGIBAUD PATRICK RENE

2 patents

VIALARD JORGE EDUARDO

2 patents

SAXTY GORDON

1 patent

FREYNE EDDY JEAN EDGARD

1 patent

MEVELLEC LAURENCE ANNE

1 patent

BOSMANS JEAN-PAUL RENE MARIE ANDRE

1 patent

Angibaud Patrick René

1 patent

PAPANIKOS ALEXANDRA

1 patent